Alex Aronov, Ph.D., Vertex Pharmaceuticals

Alex Aronov, Ph.D.

Alex Aronov received his PhD in chemistry from the University of Washington, and completed his postdoctoral training in computer-aided drug design (CADD) at UCSF. He started his industrial career in 2001 as a CADD scientist within the drug discovery unit of Vertex Pharmaceuticals in Cambridge, MA, involved in projects across a range of therapeutic areas from oncology to inflammation, and from rare diseases to antivirals. From 2007 to 2012, he led a cross-functional team to deliver a novel immune-oncology therapy BVD-723. He later led the Research Informatics at Vertex, with responsibility for Vertex’s global informatics efforts. He currently leads Vertex’s Enterprise Data Science team, working with stakeholders across the business to deliver data-driven solutions. Alex is an author of over 30 peer-reviewed manuscripts, and is an inventor on over 40 international patent applications. He holds an MBA from MIT Sloan.


9:00 AM - 9:25 AM

Breaking through the Bottleneck: A multi-omics Perspective on How Best to Use Data

How to best use data seems simple and straightforward, but in reality it is complicated and ambiguous. This high-powered session will cover how to best generate, evaluate and translate biomedical data into drug targets that lead to transformational, safe and effective medicines.
  • What AI/ML tools can support the phases of transitioning data from information to insight
  • What are the underlying infrastructure and data management systems that need to be in place to achieve these outcomes
  • How do you create a data ecosystem that translates and integrates diverse data from both internal and external partners into insight
  • AI tools that you can deploy to ensure data is an ongoing entity that evolves, continues to learn, and grows


  • Alex Aronov, Ph.D.

    Alex Aronov, Ph.D. Senior Director and Head, Enterprise Data Science Vertex Pharmaceuticals

  • Dr. Gunaretnam (Guna) Rajagopal

    Dr. Gunaretnam (Guna) Rajagopal VP Global Head – Computational Sciences, Discovery Sciences Janssen Research & Development, A Johnson & Johnson Company

Download Latest Agenda